<?xml version="1.0" encoding="UTF-8"?>
<p>TMP is the shorter title of tetra-
 <italic>O</italic>-methyl nordihydroguaiaretic acid. It is a methylated derivative of NDGA and was also initially founded in the resin of the creosote bush [
 <xref rid="B26-molecules-25-00183" ref-type="bibr">26</xref>]. As the derivative of NDGA, it was tested the antiviral effects against WNV and ZIKV simultaneously with NDGA; the results showed both compounds inhibited the infection of WNV and ZIKA, with good and similar IC
 <sub>50</sub> values, and MOA was likely by impairing viral replication [
 <xref rid="B24-molecules-25-00183" ref-type="bibr">24</xref>]. Meanwhile, Pollara showed that TMP inhibits poxvirus growth in vitro by preventing the efficient spread of virus particles from cell to cell [
 <xref rid="B27-molecules-25-00183" ref-type="bibr">27</xref>]. Additionally, there were some reports regarding the antiviral activity of TMP against herpes simplex virus (HSV) and human immunodeficiency virus (HIV) [
 <xref rid="B28-molecules-25-00183" ref-type="bibr">28</xref>,
 <xref rid="B29-molecules-25-00183" ref-type="bibr">29</xref>]. Moreover, it was made into vaginal ointment for women with HPV-linked cervical intraepithelial neoplasia and it showed an excellent safety profile in Phase I/II trials [
 <xref rid="B30-molecules-25-00183" ref-type="bibr">30</xref>].
</p>
